This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Sources searched to identify primary studies
MEDLINE and Cochrane databases were searched using the keywords "mammaplasty", "TRAM flap", "DIEP flap", "cost effectiveness", "cost utility analysis" and "breast reconstruction".
Criteria used to ensure the validity of primary studies
Not stated.
Methods used to judge relevance and validity, and for extracting data Not stated.
Number of primary studies included
Fourteen primary studies were included in the review.
Methods of combining primary studies
Data were extracted from the relevant publications and summarised to give the number of patients involved and the specific complications.
Investigation of differences between primary studies
Not reported.
Results of the review
The probability of total flap failure was 0.017 in the TRAM group and 0.014 in the DIEP group. The probability of hernia was 0.054 in the TRAM group and 0.008 in the DIEP group. The probability of abdominal wall weakness was 0.103 in the TRAM group and 0.041 in the DIEP group. The probability of partial flap loss was 0.049 in the TRAM group and 0.045 in the DIEP group. The probability of fat necrosis was 0.120 in the TRAM group and 0.085 in the DIEP group. The probability of haematoma was 0.025 in the TRAM group and 0.007 in the DIEP group.
Measure of benefits used in the economic analysis
The QALYs were used to measure benefit. These were calculated on the basis of the duration of the health state, the utility of the health state, the difference in the number of healthy years remaining and duration of health state, and the utility of successful breast reconstruction (formula given). The weights were based on the opinion of 32 experts across Canada.
